NIH-funded research R01 grant

Handheld imaging to map skin changes in autoimmune disease

Official title: Handheld Spatial Frequency Domain Imaging using Spiral Illumination for Skin Imaging

Funded at Boston University (Charles River Campus) · NIH-11381002 · Data updated 2026-11-12

A small, non-invasive handheld device uses light to map skin changes in autoimmune diseases like systemic sclerosis to help catch the disease early.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University (Charles River Campus)
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2025
Project endApril 30, 2029
Funding year2026
Award (this year)$623,036
NIH project number5R01EB037660-02
Project IDNIH-11381002 on NIH RePORTER

Who could benefit from this research

Could help

Adults with systemic sclerosis or related autoimmune skin involvement who can undergo non-invasive skin imaging.

Less likely to help

Patients without autoimmune skin involvement or those unable to tolerate non-invasive imaging.

What this research studies

This project centers on using a portable optical imaging technique called spatial-frequency domain imaging (SFDI) to measure skin properties in people with systemic sclerosis and other autoimmune conditions. The goal is to provide objective, repeatable skin assessments that can detect subtle changes early, potentially guiding timely treatment. It’s designed to be quick, painless, and suitable for repeated use in clinic or research settings, with results that clinicians can track over time. By focusing on skin involvement, the study aims to improve understanding of disease progression and response to therapy from the patient’s perspective.

Why it matters

Potential benefit: If successful, patients could receive earlier and more accurate monitoring of skin involvement, potentially improving outcomes through timely treatment adjustments.

How similar studies have gone: Preliminary data show SFDI can detect skin changes not visible by palpation in systemic sclerosis, suggesting potential for reliable skin monitoring.

Where this research is happening

  • Boston University (Charles River Campus)
    Boston, United States
    Active

Researchers

  • Principal investigator: Roblyer, Darren Michael — Boston University (Charles River Campus)
  • Study coordinator: Roblyer, Darren Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.